Related Experiment Video
Updated: Dec 9, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Clinical cure strategy for hepatitis B: immunomodulatory therapy]
1Department of Infectious Diseases, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China.
Chronic hepatitis B (CHB) is a global health issue. New strategies combining antiviral and immune therapies are needed to achieve clinical cure for most patients with chronic hepatitis B virus (HBV) infection.
Area of Science:
- Hepatology
- Immunology
- Virology
Background:
- Chronic hepatitis B virus (HBV) infection is a significant global health concern.
- Current treatment guidelines aim for clinical cure, but existing antiviral therapies are often insufficient for most patients.
- The difficulty in achieving clinical cure necessitates exploring novel therapeutic strategies.
Purpose of the Study:
- To investigate new treatment strategies for chronic hepatitis B (CHB).
- To explore the potential of immune intervention in restoring the liver microenvironment's immune response.
- To evaluate the combination of antiviral and immunomodulatory drugs for achieving clinical cure in CHB.
Main Methods:
- Review of current treatment guidelines and limitations for CHB.
- Analysis of the role of immune antiviral responses in HBV clearance.
- Exploration of novel therapeutic approaches combining antiviral and immunomodulatory agents.
Main Results:
- Existing antiviral treatments have limitations in achieving clinical cure for the majority of CHB patients.
- Immune antiviral responses are critical for effective HBV clearance.
- Optimized combination therapy involving antiviral and immunomodulatory drugs shows promise for clinical cure.
Conclusions:
- Achieving clinical cure for chronic hepatitis B requires strategies beyond current antiviral treatments.
- Immune intervention is a key component in developing effective therapies for CHB.
- A combination of antiviral and immunomodulatory drugs represents a promising approach for the clinical cure of chronic hepatitis B.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Retrovirus Life Cycles
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF